Ignite Creation Date:
2024-05-05 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 9:44 AM
Study NCT ID:
NCT00606593
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2008-01-04
Brief Title:
Almorexant ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Sponsor:
Midnight Pharma LLC
Organization:
Midnight Pharma LLC
Study Overview
Official Title:
Multicenter Double-blind Randomized Placebo-controlled 5-period 5-treatment Crossover Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A 2-night polysomnography 5-way cross-over study to evaluate the effect safety and tolerability of oral administration of almorexant ACT 078573 in elderly subjects with primary insomnia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None